SCHEMBL5533028

SCHEMBL5533028

CC(C)c1ccc(NC(N)=O)cc1

nearest known ligand 0.89

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 2/20 0.89
NPC1 O15118 3/20 0.61
GLA P06280 1/20 0.59
GRIN2D O15399 1/20 0.58
GRIN3B O60391 1/20 0.58
GRIN1 Q05586 1/20 0.58
GRIN2A Q12879 1/20 0.58
GRIN2B Q13224 1/20 0.58
GRIN2C Q14957 1/20 0.58
GRIN3A Q8TCU5 1/20 0.58
SIGMAR1 Q99720 1/20 0.58
CA12 O43570 2/20 0.57
CA1 P00915 2/20 0.57
CA2 P00918 2/20 0.57
CA9 Q16790 2/20 0.57
PEPD P12955 1/20 0.57
SMN1; SMN2 Q16637 3/20 0.56
RAB9A P51151 3/20 0.56
HPGD P15428 1/20 0.56
MEN1 O00255 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5427819 0.94 KIF11 (1.00) KIF11NPC1GLAGRIN2DGRIN3B
SCHEMBL12894680 0.84 KIF11 (0.66) KIF11NPC1GRIN2DGRIN3BGRIN1
SCHEMBL7663512 0.84 KIF11 (0.66) KIF11NPC1GLAGRIN2DGRIN3B
SCHEMBL19707622 0.83 RAB9A (0.76) KIF11NPC1CA12CA1CA2
SCHEMBL2172516 0.82 KIF11 (0.64) KIF11NPC1GLAPEPDMEN1
SCHEMBL2818448 0.82 KIF11 (0.64) KIF11NPC1GLAPEPDMEN1
SCHEMBL5062623 0.82 PEPD (0.80) KIF11NPC1GLACA1CA2
SCHEMBL13881478 0.81 KIF11 (0.62) KIF11NPC1GRIN2DGRIN3BGRIN1
SCHEMBL30140931 0.81 KIF11 (0.62) KIF11NPC1GLACA12CA1
SCHEMBL1027400 0.81 KIF11 (0.61) KIF11NPC1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240262801-A1 COMPOUNDS HAVING 5-(2-FLUORO-6-HYDROXYPHENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE AS INHIBITORS OF PROTEIN KINASE PHOSPHATASE ENZYMES MONDEGO BIO, LDA. (PT) 2024-08-08 US claimed
CN-1146320-C Enhancement of seed yield of soybeans by substituted benzoyl urea 尤尼罗亚尔化学公司 2004-04-21 CN claimed
CN-1406110-A Enhancement of seed/fruit/nut yield from flowering plants UNIROYAL CHEM CO INC (US) 2003-03-26 CN claimed
CN-1272040-A Enhancement of seed yield of soybeans by substituted benzoyl urea UNIROYAL CHEM CO INC (US) 2000-11-01 CN claimed
CN-1221316-A Benzoylurea insecticides on gene-modified Bt cotton UNIROYAL CHEM CO INC (US) 1999-06-30 CN claimed
US-5696110-A ANTIULCER AGENTS MERCK, SHARP & DOHME, LTD. (GB) 1997-12-09 US claimed
CN-1063279-A The method of synthetic herbicide isoproturon SHANDONG TEACHERS UNIVERSITY (CN) 1992-08-05 CN claimed
US-20240262801-A1 COMPOUNDS HAVING 5-(2-FLUORO-6-HYDROXYPHENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE AS INHIBITORS OF PROTEIN KINASE PHOSPHATASE ENZYMES MONDEGO BIO, LDA. (PT) 2024-08-08 US disclosed
CN-114213286-B Synthetic method of urea derivative 湖北文理学院 2022-12-30 CN disclosed
WO-2022133034-A1 METHODS OF TREATING DISORDERS ASSOCIATED WITH CASTOR ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. (US) 2022-06-23 WO disclosed
CN-114213286-A Synthetic method of urea derivative 湖北文理学院 2022-03-22 CN disclosed
US-20210371413-A1 POLYCYCLIC AMIDES AS CYTOTOXIC AGENTS Pheon Therapeutics Ltd. (GB) 2021-12-02 US disclosed
US-20210107923-A1 CYTOTOXIC AGENTS PHEON THERAPEUTICS LTD (GB) 2021-04-15 US disclosed
WO-1997045017-A1 BENZOYLUREA INSECTICIDES ON GENE-MODIFIED Bt COTTON UNIROYAL CHEMICAL COMPANY, INC. (US) 1997-12-04 WO disclosed
CN-1063279-A The method of synthetic herbicide isoproturon SHANDONG TEACHERS UNIVERSITY (CN) 1992-08-05 CN disclosed
CN-1063279-A The method of synthetic herbicide isoproturon SHANDONG TEACHERS UNIVERSITY (CN) 1992-08-05 CN disclosed
EP-0182166-B1 PROCESS FOR PREPARING PHENYLISOPROPYLUREA COMPOUNDS AMERICAN CYANAMID COMPANY (US) 1989-05-31 EP disclosed
US-4814499-A CONDENSATION OF ANILINE, UREA, AMINE RHONE-POULENC AGROCHIMIE (FR) 1989-03-21 US disclosed
EP-0182166-A2 Process for preparing phenylisopropylurea compounds AMERICAN CYANAMID COMPANY (US) 1986-05-28 EP disclosed
US-4578513-A Process for preparing phenylisopropylurea compounds AMERICAN CYANAMID COMPANY (US) 1986-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210371413-A1 POLYCYCLIC AMIDES AS CYTOTOXIC AGENTS PBRM1, NFATC1, ACIN1 KIF11 1841/4885NPC1 2212/4885GLA 3104/4885
US-20240262801-A1 COMPOUNDS HAVING 5-(2-FLUORO-6-HYDROXYPHENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE AS INHIBITORS OF PROTEIN KINASE PHOSPHATASE ENZYMES PPM1A, TH, PPM1G KIF11 3848/4885NPC1 2925/4885GLA 1587/4885
US-20210107923-A1 CYTOTOXIC AGENTS MKI67, TP53, NFATC1 KIF11 232/4885NPC1 911/4885GLA 1380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.